Bicara Therapeutics Inc (BCAX)

Finanzdaten der Bicara Therapeutics Inc-Aktie (BCAX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Operating Expenses	0.48%59.95	60.24	41.12	40.68	32.02
Operating Income/Loss	0.48%-59.95	-60.24	-41.12	-40.68	-32.02
Nonoperating Income/Loss	12.07%4.58	4.08	3.79	4.39	4.68
Income/Loss From Continuing Operations Before Tax	1.40%-55.38	-56.16	-37.33	-36.29	-27.34
Income Tax Expense/Benefit	17.31%0.06	0.05	0.05	0.04	0.05
	1.38%-55.44	-56.21	-37.39	-36.33	-27.39
Attributable To Parent	1.38%-55.44	-56.21	-37.39	-36.33	-27.39
Basic Average Shares	11.87%67.93	60.72	-	54.56	54.54
Diluted Average Shares	11.87%67.93	60.72	-	54.56	54.54
Basic Earnings Per Share	11.83%-0.82	-0.93	-	-0.67	-0.50
Diluted Earnings Per Share	11.83%-0.82	-0.93	-	-0.67	-0.50